Association between prevalence of laboratory-identified Clostridioides difficile infection (CDI) and antibiotic treatment for CDI in US acute-care hospitals, 2019
Xu K, Wu H, Li Q, Edwards J, O’Leary E, Leaptrot D, Benin A. Association between prevalence of laboratory-identified Clostridioides difficile infection (CDI) and antibiotic treatment for CDI in US acute-care hospitals, 2019. Infection Control And Hospital Epidemiology 2022, 43: 1847-1852. PMID: 35068404, PMCID: PMC10877317, DOI: 10.1017/ice.2022.6.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Bacterial AgentsClostridioides difficileClostridium InfectionsCross InfectionHospitalsHumansPrevalenceVancomycinConceptsClostridioides difficile infectionFirst-line antibioticsAcute care hospitalsCDI prevalenceAntimicrobial useSignificant dose-response associationNational Healthcare Safety NetworkUS acute care hospitalsPositive dose-response relationshipDose-response associationHospital-level variationExtreme discordanceDose-response relationshipMedical school affiliationCDI eventsDifficile infectionAntibiotic treatmentPrevalence ratesHospitalNegative binomial regressionPrevalenceTreatment practicesBinomial regressionInfectionDiscordance